VUMC Participates in National Study to Test Eye Drops for Nearsightedness in Children
August 02, 2023
August 02, 2023
NASHVILLE, Tennessee, Aug. 2 -- Vanderbilt University Medical Center issued the following news:
A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.
The first randomized . . .
A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.
The first randomized . . .